Promoting Long-Acting Buprenorphine in Prisons: A New Motivational Tool
**Introduction to the Initiative** PARIS — How can we encourage addiction research? The Association of Young Psychiatrists and Young Addiction Specialists (AJPJA), in collaboration with the French Federation of Psychiatry Students (AFFEP), sought to answer this question by organizing a research project competition. This event took place during a session on June 11 at the […]
French Researchers Identify the World’s Rarest Blood Type
Introduction to Blood Type Systems Even those with limited knowledge of hematology are familiar with the ABO and Rh systems for blood type classification. These systems categorize individuals based on the presence or absence of specific antigens on the surface of their red blood cells, resulting in blood types such as A, B, O, AB, […]
French Researchers Identify the World’s Rarest Blood Type
Introduction to Blood Type Classification Even those with limited knowledge of hematology are familiar with the ABO and Rh systems for blood type classification. These systems categorize individuals based on the presence or absence of specific antigens on the surface of red blood cells, resulting in blood groups such as A, B, O, AB, A+, […]
Promoting Long-Acting Buprenorphine in Prisons: A New Motivational Approach
**Medscape Editions** **Jean-Bernard Gervais** **August 4, 2025** **PARIS** — How can addiction research be encouraged? The Association of Young Psychiatrists and Young Addiction Specialists (AJPJA), in collaboration with the French Federation of Psychiatry Students (AFFEP), sought to answer this question by organizing a research project competition during a session at the Albatros Congress held in […]
Breakthrough in Understanding How the Human Brain Categorizes Visual Memories
Introduction to the Study Researchers at the University of Southern California have made a groundbreaking discovery in the field of neuroscience, revealing how the human brain organizes and recalls visual memories. This study, published in Advanced Science, utilizes brain recordings from human patients and an advanced machine learning model to decode the brain’s method of […]
Over 1.5 Million French Citizens Rally Against the Duplomb Law
**Introduction** On the morning of July 22, a petition filed with the French National Assembly against the Duplomb Law had amassed approximately 1,654,235 signatures, setting a new record. Initiated by Éléonore Pattery, a 23-year-old master’s student in Quality, Safety, Environment, and Corporate Social Responsibility, the petition opposes the Duplomb Law, which was passed on July […]
New Regulations on On-Call and Continuous Care Compensation: Decrees Published
Since July 1st, the compensation for on-call duties of hospital practitioners has been increased by 30% to 50%. This change comes after a period of anticipation and pressure from hospital practitioner unions. Background and Union Actions Hospital practitioner unions had been growing impatient with the government’s delay in publishing the necessary decrees. In a recent […]
Mid-July Update: Dengue, Chikungunya, and Zika Transmission in France
As of July 15, 2025, France has identified 13 episodes of local transmission of chikungunya and dengue. These cases are primarily concentrated in the southeastern regions of the country, which have been affected in previous years. However, for the first time, cases have also emerged in the Grand Est and Nouvelle-Aquitaine regions. According to Santé […]
Launch of Vimkunya Vaccine in France to Combat Chikungunya
Medscape Editions Stéphanie Lavaud July 18, 2025 The Vimkunya vaccine, designed for active immunization to prevent chikungunya virus (CHIKV) infection in individuals aged 12 and older, was launched in France on June 17, as announced by its manufacturer, Bavarian Nordic, in a press release. Vimkunya received European marketing authorization (MA) on February 28, 2025, from […]
Guselkumab Shows Promising Results in Crohn’s Disease Treatment, Surpassing Current Standards
Introduction to Guselkumab’s Breakthrough In a significant development for Crohn’s disease patients, researchers at Mount Sinai Health System have discovered that guselkumab, a medication with a novel mechanism for treating inflammatory bowel disease (IBD), has outperformed existing treatments in promoting intestinal healing and alleviating symptoms. This advancement offers new hope for those struggling with this […]